Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer model

Food and Chemical Toxicology

Volumn 93, Issue , 2016, Pages 20-31

  Urrutia Ortega, Ismael M ^a,b   Garduño Balderas, Luis G ^a,b   Delgado Buenrostro, Norma L ^a   Freyre Fonseca, Verónica ^a,c   Flores Flores, José O ^b   González Robles, Arturo ^d   Pedraza Chaverri, José ^b   Hernández Pando, Rogelio ^e   Rodríguez Sosa, Miriam ^a   León Cabrera, Sonia ^a   Terrazas, Luis I ^a   van Loveren, Henk ^f   Chirino, Yolanda I ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Azoxymethane; Colon tumors; Dextran sulfate sodium; E171 food additive; Goblet cells; Titanium dioxide

Indexed keywords

FOOD ADDITIVE; TITANIUM; TITANIUM DIOXIDE;

ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMICALLY INDUCED; COLITIS; COLORECTAL TUMOR; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GOBLET CELL; MALE; MOUSE; PATHOLOGY;

ANIMALS; CELLS, CULTURED; COLITIS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FOOD ADDITIVES; GOBLET CELLS; MALE; MICE; MICE, INBRED BALB C; TITANIUM;

EID: 84967152742     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2016.04.014     Document Type: Article

References (63)

1. Al-Henhena N., Khalifa S.A., Ying R.P., Hassandarvish P., Rouhollahi E., Al-Wajeeh N.S., Ali H.M., Abdulla M.A., El-Seedi H.R. Chemopreventive effects of Strobilanthes crispus leaf extract on azoxymethane-induced aberrant crypt foci in rat colon. Sci. Rep. 2015, 5:13312.
2. Baan R.A. Carcinogenic hazards from inhaled carbon black, titanium dioxide, and talc not containing asbestos or asbestiform fibers: recent evaluations by an IARC Monographs Working Group. Inhal. Toxicol. 2007, 19:213-228.
3. Balasubramanian S.K., Poh K.W., Ong C.N., Kreyling W.G., Ong W.Y., Yu L.E. The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. Biomaterials 2013, 34:5439-5452.
4. Bergstrom K.S., Guttman J.A., Rumi M., Ma C., Bouzari S., Khan M.A., Gibson D.L., Vogl A.W., Vallance B.A. Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen. Infect. Immun. 2008, 76:796-811.
5. Chartier C., Raval J., Axelrod F., Bond C., Cain J., Dee-Hoskins C., Ma S., Fischer M.M., Shah J., Wei J., Ji M., Lam A., Stroud M., Yen W.C., Yeung P., Cancilla B., O'Young G., Wang M., Kapoun A.M., Lewicki J., Hoey T., Gurney A. Therapeutic targeting of tumor-derived R-spondin attenuates β-catenin signaling and tumorigenesis in multiple cancer types. Cancer Res. 2016, 76:713-723.
6. Chen T., Yan J., Li Y. Genotoxicity of titanium dioxide nanoparticles. J. Food Drug Anal. 2014, 22:95-104.
7. Cooper H.S., Murthy S., Kido K., Yoshitake H., Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000, 21:757-768.
8. Dame M.K., Jiang Y., Appelman H.D., Copley K.D., McClintock S.D., Aslam M.N., Attili D., Elmunzer B.J., Brenner D.E., Varani J., Turgeon D.K. Human colonic crypts in culture: segregation of immunochemical markers in normal versus adenoma-derived. Lab. Investig. 2014, 94:222-234.
9. de Lau W., Barker N., Clevers H. WNT signaling in the normal intestine and colorectal cancer. Front. Biosci. 2007, 12:471-491.
10. Delgado-Buenrostro N.L., Medina-Reyes E.I., Lastres-Becker I., Freyre-Fonseca V., Ji Z., Hernández-Pando R., Marquina B., Pedraza-Chaverri J., Espada S., Cuadrado A., Chirino Y.I. Nrf2 protects the lung against inflammation induced by titanium dioxide nanoparticles: a positive regulator role of Nrf2 on cytokine release. Environ. Toxicol. 2015, 30:782-792.
11. Djuric Z., Turgeon D.K., Ren J., Neilson A., Plegue M., Waters I.G., Chan A., Askew L.M., Ruffin M.T., Sen A., Brenner D.E. Effects of a mediterranean diet intervention on anti- and pro-inflammatory eicosanoids, epithelial proliferation, and nuclear morphology in biopsies of normal colon tissue. Nutr. Cancer 2015, 67:721-729.
12. Dorofeyev A.E., Vasilenko I.V., Rassokhina O.A., Kondratiuk R.B. Mucosal barrier in ulcerative colitis and Crohn's disease. Gastroenterol. Res. Pract. 2013, 431:431231.
13. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Am. J. Gastroenterol. 1994, 107:1183-1188.
14. Elzagheid A., Emaetig F., Alkikhia L., Buhmeida A., Syrjänen K., El-Faitori O., Latto M., Collan Y., Pyrhönen S. High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer. Anticancer Res. 2013, 33:3137-3143.
15. Femia A.P., Dolara P., Caderni G. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 2004, 25:277-281.
16. Geraets L., Oomen A.G., Krystek P., Jacobsen N.R., Wallin H., Laurentie M., Verharen H.W., Brandon E.F., de Jong W.H. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol. 2014, 11:30.
17. Gregorieff A., Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 2005, 19:877-890.
18. Gui S., Zhang Z., Zheng L., Cui Y., Liu X., Li N., Sang X., Sun Q., Gao G., Cheng Z., Cheng J., Wang L., Tang M., Hong F. Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles. J. Hazard. Mater. 2011, 195:365-370.
19. Gupta R.A., DuBois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer 2001, 1:11-21.
20. Hajrezaie M., Hassandarvish P., Moghadamtousi S.Z., Gwaram N.S., Golbabapour S., Najihussien A., Almagrami A.A., Zahedifard M., Rouhollahi E., Karimian H., Fani S., Kamalidehghan B., Majid N.A., Ali H.M., Abdulla M.A. Chemopreventive evaluation of a schiff base derived copper (II) complex against azoxymethane-induced colorectal cancer in rats. PLoS One 2014, 9:e91246.
21. Heazlewood C.K., Cook M.C., Eri R., Price G.R., Tauro S.B., Taupin D., Thornton D.J., Png C.W., Crockford T.L., Cornall R.J., Adams R., Kato M., Nelms K.A., Hong N.A., Florin T.H., Goodnow C.C., McGuckin M.A. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008, 5:e54.
22. Hong F., Hong J., Wang L., Zhou Y., Liu D., Xu B., Yu X., Sheng L. Chronic exposure to nanoparticulate TiO2 causes renal fibrosis involving activation of the Wnt pathway in mouse kidney. J. Agric. Food Chem. 2015, 63:1639-1647.
23. Hummel T.Z., Kindermann A., Stokkers P.C., Benninga M.A., ten Kate F.J. Exogenous pigment in Peyer patches of children suspected of having IBD. J. Pediatr. Gastroenterol. Nutr. 2014, 58:477-480.
24. Inomata M., Ochiai A., Akimoto S., Kitano S., Hirohashi S. Alteration of B-catenin expression in colonic epithelial cells of familial cells adenomatous polyposis patients. Cancer Res. 1996, 56:2213-2217.
25. Jiang J., Oberdörster G., Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J. Nanopart. Res. 2009, 11:77-89.
26. Jones K., Morton J., Smith I., Jurkschat K., Harding A.H., Evans G. Human in vivo and in vitro studies on gastrointestinal absorption of titanium dioxide nanoparticles. Toxicol. Lett. 2015, 233:95-101.
27. Kim H.J., Yu M.H., Kim H., Byun J., Lee C. Noninvasive molecular biomarkers for the detection of colorectal cancer. Toxicol. Lett. 2008, 31:685-692.
28. Kobaek-Larsen M., Fenger C., Ritskes-Hoitinga J. Secondary effects induced by the colon carcinogen azoxymethane in BDIX rats. APMIS 2004, 112:319-329.
29. Koeneman B.A., Zhang Y., Westerhoff P., Chen Y., Crittenden J.C., Capco D.G. Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol. Toxicol. 2010, 26:225-238.
30. Ku J.L., Shin Y.K., Kim D.W., Kim K.H., Choi J.S., Hong S.H., Jeon Y.K., Kim S.H., Kim H.S., Park J.H., Kim I.J., Park J.G. Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers. Carcinogenesis 2010, 31:1003-1009.
31. Li L.T., Jiang G., Chen Q., Zheng J.N. Ki67 is a promising molecular target in the diagnosis of cancer. Mol. Med. Rep. 2015, 11:1566-1572.
32. Liu K., Lin X., Zhao J. Toxic effects of the interaction of titanium dioxide nanoparticles with chemicals or physical factors. Int. J. Nanomed. 2013, 8:2509-2520.
33. Longmire M., Choyke P.L., Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomed. Lond. 2008, 3:703-717.
34. MacNicoll A., Kelly M., Aksoy H., Kramer E., Bouwmeester H., Chaudhry Q. A study of the uptake and biodistribution of nano-titanium dioxide using in vitro and in vivo models of oral intake. J. Nanopart. Res. 2015, 17:66.
35. Mahmoud A.M., El-Derby A.M., Elsayed K.N.M., Abdella E.M. Brown seaweeds ameliorate renal alterations in mice treated with the carcinogen azoxymethane. Int. J. Pharm. Pharm. Sci. 2014, 6:365-369.
36. Marnett L.J., DuBois R.N. COX-2: a target for colon cancer prevention. Annu. Rev. Pharmacol. Toxicol. 2002, 42:55-80.
37. Medina-Reyes E.I., Bucio-López L., Freyre-Fonseca V., Sánchez-Pérez Y., García-Cuéllar C.M., Morales-Bárcenas R., Pedraza-Chaverri J., Chirino Y.I. Cell cycle synchronization reveals greater G2/M-phase accumulation of lung epithelial cells exposed to titanium dioxide nanoparticles. Environ. Sci. Pollut. Res. Int. 2015, 22:3976-3982.
38. Medina-Reyes E.I., Déciga-Alcaraz A., Freyre-Fonseca V., Delgado-Buenrostro N.L., Flores-Flores J.O., Gutiérrez-López G.F., Sánchez-Pérez Y., García-Cuéllar C.M., Pedraza-Chaverri J., Chirino Y.I. Titanium dioxide nanoparticles induce an adaptive inflammatory response and invasion and proliferation of lung epithelial cells in chorioallantoic membrane. Environ. Res. 2015, 136:424-434.
39. Ministry of Agriculture, Fisheries, and Food (MAFF) Dietary Intake of Food Additives in the UK: Initial Surveillance (Food Surveillance Paper 37) 1993, MAFF, London, UK, DuPont. 2007. PuPontTM Ti-Pure1 titanium dioxide. Titanium dioxide for coatings. [cited 2014 June 5]. Available from. http://www2.dupont.com/Titanium_Technologies/en_US/tech_info/literature/Coatings/CO_B_H_65969_Coatings_Brochure.pdf.
40. Nosho K., Kawasaki T., Chan A.T., Ohnishi M., Suemoto Y., Kirkner G.J., Fuchs C.S., Ogino S. Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype. Histopathology 2008, 53:588-598.
41. O'Connell J.B., Maggard M.A., Ko C.Y. Colon cancer survival rates with the new american joint committee on cancer sixth edition staging. J. Natl. Cancer Inst. 2004, 96:1420-1425.
42. Ochai M., Watanabe M., Nakanishi M., Taguchi A., Sugimura T., Nakagama H. Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats. Cancer Lett. 2005, 220:67-74.
43. Ogino S., Kirkner G.J., Nosho K., Irahara N., Kure S., Shima K., Hazra A., Chan A.T., Dehari R., Giovannucci E.L., Fuchs C.S. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin. Cancer Res. 2008, 14:8221-8227.
44. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., Taketo M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87:803-809.
45. Peters R.J., van Bemmel G., Herrera-Rivera Z., Helsper H.P., Marvin H.J., Weigel S., Tromp P.C., Oomen A.G., Rietveld A.G., Bouwmeester H. Characterization of titanium dioxide nanoparticles in food products: analytical methods to define nanoparticles. J. Agric. Food Chem. 2014, 62:6285-6293.
46. Powell J.J., Ainley C.C., Harvey R.S., Mason I.M., Kendall M.D., Sankey E.A., Dhillon A.P., Thompson R.P. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 1996, 38:390-395.
47. Reimers M.S., Zeestraten E.C., van Alphen T.C., Dekker J.W., Putter H., Saadatmand S., Liefers G.J., van de Velde C.J., Kuppen P.J. Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray. Int. J. Colorectal Dis. 2014, 29:1043-1052.
48. Rosenberg D.W., Giardina C., Tanaka T. Mouse models for the study of colon carcinogenesis. Carcinogenesis 2009, 30:183-196.
49. Setyawati M.I., Tay C.Y., Chia S.L., Goh S.L., Fang W., Neo M.J., Chong H.C., Tan S.M., Loo S.C., Ng K.W., Xie J.P., Ong C.N., Tan N.S., Leong D.T. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat. Commun. 2013, 4:1673.
50. Sharif H.A., Rasha A.E., Ramia Z.Al-B. Titanium dioxide content in foodstuffs from the Jordanian market: spectrophotometric evaluation of TiO2 nanoparticles. Int. Food Res. J. 2015, 22:1024-1029.
51. Shi H., Magaye R., Castranova V., Zhao J. Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol. 2013, 10:15.
52. Silva R.M., Campanholo V.M., Paiotti A.P., Neto R.A., Oshima C.T., Ribeiro D.A., Forones N.M. Chemopreventive activity of grape juice concentrate (G8000TM) on rat colon carcinogenesis induced by azoxymethane. Environ. Toxicol. Pharmacol. 2015, 40:870-875.
53. Takayama T., Shiozaki H., Shibamoto S., Oka H., Kimura Y., Tamura S. Inoue M, Monden T, Ito F, Monden M. Beta-catenin expression in human cancers. Am. J. Pathol. 1996, 148:39-46.
54. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003, 94:965-973.
55. Tassinari R., Cubadda F., Moracci G., Aureli F., D'Amato M., Valeri M., De Berardis B., Raggi A., Mantovani A., Passeri D., Rossi M., Maranghi F. Oral, short-term exposure to titanium dioxide nanoparticles in Sprague-Dawley rat: focus on reproductive and endocrine systems and spleen. Nanotoxicology 2014, 8:654-662.
56. Technical Report Series No. 97, 1979, CAS No. 13463-67-7 NCI-CG-TR-97.
57. Thoree V., Skepper J., Deere H., Pele L.C., Thompson R.P., Powell J.J. Phenotype of exogenous microparticle-containing pigment cells of the human Peyer's patch in inflamed and normal ileum. Inflamm. Res. 2008, 57:374-378.
58. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., Sun J., Li Y., Jiao F., Zhao Y., Chai Z. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168:176-185.
59. Wang Q.S., Papanikolaou A., Sabourin C.L., Rosenberg D.W. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis. Carcinogenesis 1998, 19:2001-2006.
60. Wang T., Chen Z., Zhu Y., Pan Q., Liu Y., Qi X., Jin L., Jin J., Ma X., Hua D. Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells. J. Biol. Chem. 2015, 290:448-456.
61. Warheit D.B., Brown S.C., Donner E.M. Acute and subchronic oral toxicity studies in rats with nanoscale and pigment grade titanium dioxide particles. Food Chem. Toxicol. 2015, 84:208-224.
62. Weir A., Westerhoff P., Fabricius L., Hristovski K., von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 2012, 46:2242-2250.
63. Yoshida N., Kinugasa T., Ohshima K., Yuge K., Ohchi T., Fujino S., Shiraiwa S., Katagiri M., Akagi Y. Analysis of Wnt and β-catenin expression in advanced colorectal cancer. Anticancer Res. 2015, 35:4403-4410.